Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The UK's Medical Research Council (MRC) has confirmed renewal of funding for Dementias Platform UK (DPUK), in partnership with industry and the third sector.

DPUK logo and people working

The renewal means DPUK will receive a further £7.5m from the MRC, with up to £8.5m from partners, in support of its aims. DPUK’s mission is to accelerate progress in dementia research by identifying the early signs of disease and supporting the translation of scientific discoveries into potential new treatments and preventive strategies.

Professor John Gallacher, Director of DPUK , said,

 

‘We are delighted to be able to confirm our renewed MRC funding, which means that many more scientists will have access to the technology, support and research resources needed to transform our understanding of dementia.

 

To read the full story.

For more information about the Dementias Platform UK.